
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity is well-positioned for growth and margin expansion, driven by continued market share penetration, increasing penetration of its Enhanced Rates product, and leveraging technology to drive down service costs. The regulatory landscape is also favorable for potential TAM expansion. With attractive valuation and solid execution, the company is a strong buy opportunity for investors.
Bears say
HealthEquity is facing potential challenges as the market for health savings accounts (HSAs) is highly competitive and oversaturated, and their growth may slow significantly due to a weakening labor market and lower adoption rates for enhanced yield offerings. While the company has shown strong account growth and a diversified product portfolio, our downside scenario assumes slower growth and margin contraction, leading to a $79 price target. However, there is potential for an upside scenario with a $119 price target if the company achieves better-than-expected penetration of enhanced rates, accelerated growth in other consumer-directed benefits, and continued benefits from technology investments.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares